Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination

N Engl J Med. 2021 Sep 2;385(10):951-953. doi: 10.1056/NEJMc2108829. Epub 2021 Jul 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / blood
  • Antibodies, Viral / blood
  • COVID-19 Vaccines / immunology*
  • Follow-Up Studies
  • Humans
  • Immunity, Cellular*
  • Immunity, Humoral*
  • Immunogenicity, Vaccine*
  • SARS-CoV-2
  • T-Lymphocytes / physiology
  • Vaccination

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Ad26.COV2.S vaccine

Supplementary concepts

  • SARS-CoV-2 variants